Skip to main content
Have a personal or library account? Click to login
The efficacy of manualized Cognitive Behavior Therapy conducted by student-therapists treating Danish youths with anxiety using a benchmark comparison Cover

The efficacy of manualized Cognitive Behavior Therapy conducted by student-therapists treating Danish youths with anxiety using a benchmark comparison

Open Access
|Nov 2019

Figures & Tables

TABLE 1.

Demographic and diagnostic characteristics for youths in student therapist and professional therapist group

Youths in ST group (n= 54)Youths in PT group (n= 56)
Mean age in years (SD)10.18 (1.46)11.82 (2.49)
Males (%)32 (59.3)25 (44.6)
On psychopharmacological medication3 (6.7)2 (4.5)
Primary diagnosis (%)
SAD24 (44.4)15 (26.8)
GAD15 (27.8)14 (25.0)
SoP7 (13.0)7 (12.5)
SP6 (11.1)12 (21.4)
OCD1 (1.9)4 (7.1)
AP without PD1 (1.9)4 (7.1)
CSR mean for primary diagnosis6.33 (0.75)6.09 (1.07)
CSR mean for all diagnosis4.60 (1.33)5.32 (0.95)
Comorbid diagnoses (%)
Anxiety disorders50 (92.6)47 (83.9)
Externalizing disorders6 (11.2)6 (10.7)
Mood disorder1 (1.9)4 (7.1)
Other4a(7.4)3a(5.4)
No comorbidity4 (7.4)9 (16.1)
Number of anxiety disorders per youth (M)2.362.10

1 Notes:ST, student therapist; PT, professional therapist; SAD, separation anxiety disorder; GAD, generalized anxiety disorder; SoP, social phobia; PD, panic disorder; OCD, obsessive compulsive disorder; SP, specific phobia; AP, agoraphobia; CSR, clinician severity rating (ADIS C/P-IV)

2a 4 enuresis

3b 1 sleep terror disorder, 1 selective mutism, 1 enuresis

TABLE 2.

Continuous measure outcomes at pre- and post-treatment for student therapist and professional therapist groups, the time-by-group effect and ES

Pre –M(SD)Post –M(SD)Time-by-group effectPre-post ES
ADIS CSR primary diagnosis
ST6.33 (0.75)2.85 (2.41)F1,108= 0.18,p= 0.72,ηp2=0.01p< 0.001,g= 1.36
PT6.09 (1.07)2.16 (2.59)p< 0.001,g= 1.51
ADIS CSR all diagnoses
ST4.60 (1.32)2.13 (1.36)F1,108= 0.52,p= 0.47,ηp2=0.01p< 0.001,g= 1.82
PT5.32 (0.95)1.69 (1.53)p< 0.001,g= 2.52
SCAS youth
ST41.57 (16.93)24.13 (14.36)F1,108= 0.80,p= 0.37,ηp2=0.00p< 0.001,g= 1.08
PT39.16 (18.06)21.57 (14.42)p< 0.001,g= 1.03
SCAS-P mother
ST43.72 (14.98)23.76 (11.90)F1,108= 1.94,p= 0.27ηp2=0.02p< 0.001,g= 1.41
PTa38.91 (15.79)22.25 (12.59)p< 0.001,g= 1.12
SCAS-P father
ST38.18 (15.33)22.55 (12.57)F1,102= 0.00,p= 0.99,ηp2=0.00p< 0.001,g= 1.07
PT37.15 (13.80)23.56 (13.87)p< 0.001,g= 0.97
CALIS youth
ST15.10 (8.09)7.57 (6.40)F1,108= 1.87,p= 0.17,ηp2=0.01p< 0.001,g= 0.99
PT11.90 (7.35)7.55 (6.46)p< 0.001,g= 0.61
CALIS mother
ST19.65 (6.80)12.06 (7.28)F1,108= 1.89,p= 0.17,ηp2=0.01p< 0.001,g= 1.06
PT17.78 (7.20)10.61 (7.28)p< 0.001,g= 0.98
CALIS father
ST18.51 (6.93)11.90 (6.29)F1,102= 1.96,p= 0.17,ηp2=0.02p< 0.001,g= 0.98
PT16.05 (6.84)10.96 (7.72)p< 0.001,g= 0.68
CALIS-P mother
ST13.13 (5.72)7.26 (5.66)F1,108= 1.39,p= 0.24,ηp2=0.01p< 0.001,g= 1.02
PT11.07 (6.91)6.82 (6.28)p< 0.001,g= 0.63
CALIS-P father
ST10.16 (5.65)6.86 (4.63)F1,102= 3.17,p= 0.08,ηp2=0.03p< 0.001,g= 0.62
PT7.85 (6.09)5.71 (5.46)p< 0.001,g= 0.32

1 Notes.ST, student therapist; PT, professional therapist; ES, effect-size; ADIS, Anxiety Disorder Interview Schedule for DSM-IV; CSR, Clinician Severity Rating; SCAS, Spence Children’s Anxiety Scale; SCAS-P, Spence Children’s Anxiety Scale Parent version; CALIS, Child Anxiety Life Interference Scale; CALIS-P, Child Anxiety Life Interference Scale – Interference on parents’ life

2a Outlier excluded

TABLE 3.

Continuous measure outcomes at pre- and FU-treatment for the student therapist and professional therapist groups, the time-by-group effect and ES

Pre –M(SD)FU -M(SD)Time-by-group effectPre-FU ES
ADIS CSR primary diagnosis
ST6.33 (0.75)1.74 (2.31)F1, 108 = 1.53,p= 0.22,ηp2= 0.01p< 0.01,g= 1.88
PT6.09 (1.07)1.59 (2.49)p< 0.01,g= 1.81
ADIS CSR all diagnoses
ST4.60 (1.32)1.37 (1.22)F1, 108 = 0.13,p= 0.72,ηp2= 0.00p< 0.01,g= 2.51
PT5.32 (0.95)1.28 (1.32)p< 0.01,g= 3.27
SCAS youth
ST41.57 (16.93)20.91 (12.95)F1, 108 = 1.47,p= 0.23,ηp2= 0.01p< 0.01,g= 1.30
PT39.16 (18.06)16.70 (13.23)p< 0.01,g= 1.33
SCAS-P mother
ST43.72 (14.98)21.72 (11.53)F1, 108 = 1.49,p= 0.22,ηp2= 0.01p< 0.01,g= 1.56
PTa38.91 (15.79)19.79 (13.61)p< 0.01,g= 1.26
SCAS-P father
ST38.18 (15.33)18.70 (12.55)F1, 102 = 0.00,p= 0.99,ηp2= 0.00p< 0.01,g= 1.34
PT37.15 (13.80)18.72 (10.63)p< 0.01,g= 1.42
CALIS youth
ST15.10 (8.09)8.50 (8.21)F1, 108 = 3.30,p= 0.07,ηp2= 0.03p< 0.01,g= 0.80
PT11.90 (7.35)5.79 (6.07)p< 0.01,g= 0.88
CALIS mother
ST19.65 (6.80)10.13 (7.09)F1, 108 = 1.70,p= 0.20,ηp2= 0.02p< 0.01,g= 1.35
PT17.78 (7.20)8.80 (7.75)p< 0.01,g= 1.18
CALIS father
ST18.51 (6.93)8.83 (6.67)F1, 102 = 0.41,p= 0.53,ηp2= 0.00p< 0.01,g= 1.40
PT16.05 (6.84)10.00 (7.85)p< 0.01,g= 0.80
CALIS-P mother
ST13.13 (5.72)6.39 (5.12)F1, 108 = 1.10,p= 0.30,ηp2= 0.01p< 0.01,g= 1.22
PT11.07 (6.91)5.68 (6.83)p< 0.01,g= 0.77
CALIS-P father
ST10.16 (5.65)5.27 (5.10)F1,102 = 2.25,p= 0.14,ηp2= 0.02p< 0.01,g= 0.89
PT7.85 (6.09)4.65 (4.77)p< 0.01,g= 0.56

1 Notes.ST, student therapist; PT, professional therapist; ES, effect-size; ADIS, Anxiety Disorder Interview Schedule for DSM-IV; CSR, Clinician Severity Rating; SCAS, Spence Children’s Anxiety Scale; SCAS-P, Spence Children’s Anxiety Scale Parent version; CALIS,Child Anxiety Life Interference Scale; CALIS-P, Child Anxiety Life Interference Scale - interference on parents life

2a Outlier excluded

FIGURE 1

Mean scores on SCAS, SCAS-P and CSR primary diagnosis for both treatment groups, at pre-, post-treatment and 3-month follow-up

Note.CSR = Clinician Severity Rating, SCAS = Spence Children’s Anxiety Scale

TABLE 4.

Proportion of youths no longer meeting criteria for primary anxiety diagnosis and all anxiety diagnosis at post-treatment and follow-up

ST group (n= 54)PT group (n= 56)Fischer’s
Post-treatment
Primary diagnosis50.0% (27)66.1% (37)p= 0.122
All diagnosis25.9% (14)48.2% (27)p= 0.019*
Follow up
Primary diagnosis74.1% (40)76.8% (43)p= 0.826
All diagnosis46.3% (25)58.9% (33)p= 0.252

1 Notes.ST, student therapist; PT, professional therapist

2* Significant atp< 0.05

TABLE 5.

Reliable and clinical significant changes at post-treatment and 3-month follow-up on SCAS, for intention to treat sample

SCAS YouthSCAS-P MotherSCAS-P Father
ST (n= 54)PT (n= 56)Fisher’sST (n= 54)PT (n= 56)Fisher’sST (n= 51a)PT (n= 53b)Fisher’s
Pre-treatment
Over clinical cut-off75.9% (41)67.9% (38)p= 0.4090.7% (49)85.7% (48)p= 0.5678.4% (40)84.9% (45)p= 0.45
Post-treatment
RC deterioration0% (0)0% (0)-0% (0)0% (0)-0% (0)1.9% (1)p= 0.99
RC improvement63.0% (34)67.9% (38)p= 0.6981.5% (44)69.6% (39)p= 0.1974.5% (38)71.7% (38)p= 0.83
RC but not CSC18.5% (10)19.6% (11)p= 0.9933.3% (18)12.5% (7)p= 0.01*17.6% (9)32.1% (17)p= 0.11
CSC44.4% (24)48.2% (27)p= 0.7148.1% (26)57.1% (32)p= 0.4556.9% (29)41.5% (22)p= 0.17
Three-month follow-up
RC deterioration0% (0)5.4% (3)p= 0.245.6% (3)10.7% (6)p= 0.497.8% (4)5.7% (3)p= 0.71
RC improvement63.0% (34)50.0% (28)p= 0.1877.8% (42)66.1% (37)p= 0.2166.7% (34)56.6% (30)p= 0.32
RC but not CSC3.7% (2)19.6% (11)p= 0.02*14.8% (8)28.6% (16)p= 0.1121.6% (11)15.1% (8)p= 0.45
CSC59.3% (32)35.7% (20)p= 0.02*68.5% (37)48.2% (27)p= 0.04*52.9% (27)47.2% (25)p= 0.70

1 Notes: ST, student therapist; PT, professional therapist; RC, reliable change; CSC, clinical significant change; SCAS, Spence Children’s Anxiety Scale; SCAS-P, Spence Children’s Anxiety Scale Parent version.

2a 3 fathers did not participate;

3b 3 fathers did not participate

4* Significant atp< 0.05

Language: English
Page range: 68 - 80
Published on: Nov 20, 2019
Published by: Center for Evidence-based Psychiatry
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2019 Daniel Bach Johnsen, Kristian Arendt, Mikael Thastum, published by Center for Evidence-based Psychiatry
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.